Purchase Order 19PCRD26K1496
Award Date 12/8/25
Potential Completion Date 1/2/26
Potential Value $25K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27701, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Bureau of Administration awarded a $24,928.33 firm fixed-price purchase order to GlaxoSmithKline, LLC for medical supplies on December 8, 2025, with an ultimate completion date of January 2, 2026. The contract, which carries no set-aside designation, will be performed in Durham, North Carolina, where GlaxoSmithKline maintains its headquarters. As a foreign-owned pharmaceutical company, GlaxoSmithKline serves as a prime contractor and supplier of vaccines, antiviral medications, and...
- The U.S. Bureau of Administration awarded a firm fixed-price purchase order to Glaxosmithkline, LLC for medical supplies with a ceiling value of $24,928.33. The contract, which was awarded on December 8, 2025, will be performed in Durham, North Carolina, with an ultimate completion date of January 2, 2026. This procurement does not carry a set-aside designation and represents a relatively modest delivery order within Glaxosmithkline's broader federal contract portfolio. Glaxosmithkline is a...
- Glaxosmithkline, LLC was awarded a $24,000 Blanket Purchase Agreement (BPA) call for vaccines by a civilian federal agency with an ultimate completion date of December 31, 2026. The award, made on February 27, 2026, utilizes a firm fixed price contract structure with no set-aside designation. The place of performance is Durham, North Carolina, where Glaxosmithkline maintains its headquarters. This BPA call represents a delivery order against an existing blanket purchase agreement vehicle,...
- The U.S. government agency, the Medical Supply Chain, has awarded a $1,400.00 firm fixed price delivery order contract to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. This contract has no set-aside designation and the performance will take place at Glaxosmithkline's facilities in Durham, North Carolina. Glaxosmithkline has also received several other federal contracts and grants to supply a range of pharmaceutical products and services, including...
- The U.S. government's Bureau of Administration, a civilian agency, awarded a firm fixed-price delivery order contract to GlaxoSmithKline, LLC for the provision of 2025-2026 influenza vaccines. The contract has a ceiling value of $667,575.00 and an ultimate completion date of October 9, 2025. This award is not set aside for any specific business type. GlaxoSmithKline, a foreign-owned, for-profit pharmaceutical company, has been a critical supplier of vaccines, antivirals, and medical...
- This is a $144,059.82 firm fixed price delivery order awarded by the Department of Health and Human Services to Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, to provide vaccines and other pharmaceutical products. The contract is issued under the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The delivery order supports disease prevention efforts, immunization programs, and healthcare services, with performance in...
- This federal contract award was issued by the Department of Health and Human Services Office of the Assistant Secretary for Administration to Glaxosmithkline, LLC, doing business as Glaxosmithkline, a pharmaceutical company that supplies vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The $166,571.80 firm fixed price delivery order is for the provision of vaccines, with no set-aside designation. It is associated with Glaxosmithkline's General...
- The Department of Health and Human Services awarded a $121,391.84 firm fixed-price delivery order to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of vaccines. This award is part of a larger General Services Administration Federal Supply Schedule 61 contract for pharmaceuticals and drugs. The contract does not have a set-aside designation and the place of performance is Glaxosmithkline's facility in Research Triangle Park, North Carolina. Glaxosmithkline is a major supplier...
- This is a federal contract award to Glaxosmithkline, LLC, a pharmaceutical company, by the Office of the Assistant Secretary for Administration, a civilian agency. The $137,825.42 firm fixed price delivery order contract is for the provision of vaccines under the Pharmaceuticals and Drugs Federal Supply Schedule. There is no set-aside designation. The contract supports the agency's disease prevention and immunization programs. Glaxosmithkline has previously provided a range of pharmaceutical...
- This contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to the prime contractor Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, to provide vaccines for the government's stock. The $172,923.02 firm fixed price delivery order was issued under Glaxosmithkline's Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs. The award does not have a set-aside designation. Glaxosmithkline is a...